WSO - April 2023 - 482

482
International Journal of Stroke 18(4)
GNT1182071). The study is coordinated by the Menzies
Institute for Medical Research (University of Tasmania).
The Steering Committee is responsible for the management
of the trial including design, conduct, analysis, and publication.
Ethics approvals have been provided by relevant jurisdictions
(Tasmania (approval no. H0023615), New Zealand
(grant no. 20/CEN/280), Monash (grant no. 28076), and
Adelaide (grant no. 23615/MYIP14916) (Supplementary
Materials 2)). Results will be disseminated through publications
with authors meeting International Committee of
Medical Journal Editors guidelines.
Discussion
PERKS-International will provide evidence of the efficacy
of the Stroke Riskometer mobile phone app to modify risk
factors for stroke. In designing the study, we have been
mindful of the need to replicate how The App would be
used in the real world, including minimal input from study
staff and electronic data collection. If this simple, affordable,
and widely available technology improves stroke risk
factors, it could potentially translate into a 4% reduction in
stroke.31 This trial will fill a critical gap contributing to the
primary prevention of stroke.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article: The
authors report funding from the National Health and Medical
Research Council of Australia (GNT1182071) and the National
Heart Foundation of Australia (SLG 102061).
ORCID iDs
Seana L Gall
Valery Feigin
Amanda G Thrift
682X
Tara Purvis
Dominique A Cadilhac
https://orcid.org/0000-0002-5138-2526
https://orcid.org/0000-0002-6372-1740
https://orcid.org/0000-0001-8533-4170
https://orcid.org/0000-0001-8162https://orcid.org/0000-0003-3332-5357
Supplemental
material
Supplemental material for this article is available online.
References
1. Feigin VL, Nguyen G, Cercy K, et al. Global, regional, and
country-specific lifetime risks of stroke, 1990 and 2016. N
Engl J Med 2018; 379: 2429-2437.
2. Hankey GJ. Ischaemic stroke-Prevention is better than cure.
J R Coll Physicians Edinb 2010; 40: 56-63.
International Journal of Stroke, 18(4)
3. O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and
regional effects of potentially modifiable risk factors associated
with acute stroke in 32 countries (INTERSTROKE): a
case-control study. Lancet 2016; 388: 761-775.
4. Han L, You D, Ma W, et al. National Trends in American
Heart Association revised Life's Simple 7 metrics associated
with risk of mortality among US adults. JAMA Netw Open
2019; 2: e1913131.
5. Krishnamurthi R, Hale L, Barker-Collo S, et al. Mobile
technology for primary stroke prevention. Stroke 2018; 50:
196-198.
6. Parmar P, Krishnamurthi R, Ikram MA, et al. The Stroke
Riskometer (TM) app: validation of a data collection tool and
stroke risk predictor. Int J Stroke 2015; 10: 231-244.
7. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for
the primary prevention of stroke: a statement for healthcare
professionals from the American Heart Association/American
Stroke Association. Stroke 2014; 45: 3754-3832.
8. Beratarrechea A, Lee AG, Willner JM, et al. The impact of
mobile health interventions on chronic disease outcomes in
developing countries: a systematic review. Telemed J E Health
2014; 20: 75-82.
9. Feigin VL, Norrving B, George MG, et al. Prevention of
stroke: a strategic global imperative. Nat Rev Neurol 2016;
12: 501-512.
10. Cajita MI, Zheng Y, Kariuki JK, et al. mHealth technology
and CVD risk reduction. Curr Atheroscler Rep 2021; 23:
36.
11. Lloyd-Jones Donald M, Hong Y, Labarthe D, et al. Defining
and setting national goals for cardiovascular health promotion
and disease reduction. Circulation 2010; 121: 586-613.
12. Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement:
defining standard protocol items for clinical trials. Ann
Int Med 2013; 158: 200-207.
13. Agarwal S, LeFevre AE, Lee J, et al. Guidelines for reporting
of health interventions using mobile phones: mobile health
(mHealth) evidence reporting and assessment (mERA) checklist.
Br Med J 2016; 352: i1174.
14. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal
Cognitive Assessment, MoCA: a brief screening tool for mild
cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
15. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium:
building an international community of software platform
partners. J Biomed Inform 2019; 95: 103208.
16. Harris PA, Taylor R, Thielke R, et al. Research electronic data
capture (REDCap)-A metadata-driven methodology and
workflow process for providing translational research informatics
support. J Biomed Inform 2009; 42: 377-381.
17. Cleghorn CL, Harrison RA, Ransley JK, et al. Can a dietary
quality score derived from a short-form FFQ assess dietary
quality in UK adult population surveys. Public Health Nutr
2016; 19: 2915-2923.
18. Booth M. Assessment of physical activity: an international
perspective. Res Q Exerc Sport 2000; 71: S114-S120.
19. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC
practice guidelines for the management of arterial hypertension.
Blood Press 2014; 23: 3-16.
20. Kroenke K, Spitzer RL and Williams JB. The PHQ-9: validity
of a brief depression severity measure. J Gen Intern Med
2001; 16: 606-613.
https://www.orcid.org/0000-0002-5138-2526 https://www.orcid.org/0000-0002-6372-1740 https://www.orcid.org/0000-0001-8533-4170 https://www.orcid.org/0000-0001-8162-628X https://www.orcid.org/0000-0001-8162-628X https://www.orcid.org/0000-0003-3332-5357
WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023
